SEM — Select Medical Holdings Income Statement
0.000.00%
Last trade - 00:00
- $3.47bn
- $7.36bn
- $6.66bn
- 81
- 70
- 68
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,454 | 5,532 | 6,205 | 6,334 | 6,664 |
Cost of Revenue | |||||
Gross Profit | 813 | 821 | 919 | 733 | 932 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,014 | 4,952 | 5,489 | 5,930 | 6,124 |
Operating Profit | 440 | 580 | 716 | 403 | 540 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 265 | 456 | 630 | 261 | 382 |
Provision for Income Taxes | |||||
Net Income After Taxes | 201 | 345 | 500 | 198 | 300 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 148 | 259 | 402 | 159 | 243 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 143 | 250 | 389 | 153 | 235 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.29 | 1.33 | 2.97 | 1.23 | 2 |
Dividends per Share |